Vaccine World MENA & CIS Summit 2014

The Vaccine World MENA & CIS Summit 2014 is dedicated to the vaccine industry in the Middle East, North Africa, CIS and CEE region.

Some interesting facts:

• Pfizer opened a pneumococcal conjugate vaccine (PCV) production plant in Istanbul in November 2012
• MSD and Saudi Biopharma Sobol signed a long-term exclusive agreement to establish a manufacturing plant for certain types of vaccines in Aug 2012
• Israeli vaccine company SciVac is seeking U.S. approval for a widely used hepatitis B vaccine for global expansion in July 2013
• Nanolek announced plans to become the first manufacturer of a VLP (virus-like particle)-based flu vaccine in Russia in May 2013
• GlaxoSmithKline (GSK) has announced plans to produce vaccines in Turkey with local company IDOL in November 2013

Who should Attend

Attendees from vaccine companies from the MENA and CIS region.